Zilucoplan has been accepted for restricted use in NHS Scotland [...]

The FDA has issued a Complete Response Letter for ITM-11, [...]

Grifols has completed patient follow-up in its Phase 3 SPARTA [...]

Acarizax has been accepted for use in NHS Scotland for [...]

BioVie has reported topline results from a Phase 2 trial [...]

Biotech company LifeMine Therapeutics has raised $263 million to support [...]

Kupando has dosed the first patient in a Phase 1 [...]

Adneuris Therapeutics has granted Maruishi Pharmaceutical exclusive rights to develop [...]

BlueWind Medical has received FDA 510(k) clearance for Revi Extend, [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]